Fleur Hudson

3.9k total citations
18 papers, 524 citations indexed

About

Fleur Hudson is a scholar working on Infectious Diseases, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Fleur Hudson has authored 18 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 7 papers in Molecular Biology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Fleur Hudson's work include HIV/AIDS Research and Interventions (11 papers), HIV/AIDS drug development and treatment (7 papers) and HIV Research and Treatment (5 papers). Fleur Hudson is often cited by papers focused on HIV/AIDS Research and Interventions (11 papers), HIV/AIDS drug development and treatment (7 papers) and HIV Research and Treatment (5 papers). Fleur Hudson collaborates with scholars based in United Kingdom, United States and Australia. Fleur Hudson's co-authors include Aparna Mahakali Zama, Mary A. Bedell, Janet Darbyshire, Angus Kennedy, Peter Rudge, John Collinge, Geraldine F. Keogh, Moira Spyer, Suvankar Pal and Dafydd J. Thomas and has published in prestigious journals such as The Lancet, PLoS ONE and Neurology.

In The Last Decade

Fleur Hudson

18 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fleur Hudson United Kingdom	12	252	194	148	91	74	18	524
Moira Spyer United Kingdom	11	186 0.7×	265 1.4×	111 0.8×	77 0.8×	39 0.5×	30	536
Kevin R. Robillard Canada	9	65 0.3×	205 1.1×	132 0.9×	25 0.3×	35 0.5×	13	437
Jamie L. Dorsey United States	12	24 0.1×	78 0.4×	159 1.1×	67 0.7×	48 0.6×	15	329
Sara Svensson Akusjärvi Sweden	10	160 0.6×	178 0.9×	106 0.7×	11 0.1×	13 0.2×	17	447
Lee C. Winchester United States	12	65 0.3×	143 0.7×	111 0.8×	16 0.2×	25 0.3×	24	304
Mohammad-Ali Jenabian Canada	14	129 0.5×	245 1.3×	426 2.9×	9 0.1×	27 0.4×	42	848
Olivia Briceño Mexico	8	87 0.3×	85 0.4×	62 0.4×	11 0.1×	12 0.2×	23	304
Shetty Ravi Dyavar United States	12	66 0.3×	183 0.9×	81 0.5×	28 0.3×	8 0.1×	19	326
Rozanne C. M. Adams South Africa	7	69 0.3×	68 0.4×	42 0.3×	10 0.1×	18 0.2×	9	365
Brian A. Sellers United States	6	211 0.8×	76 0.4×	42 0.3×	7 0.1×	21 0.3×	6	425

Countries citing papers authored by Fleur Hudson

Since Specialization

Citations

This map shows the geographic impact of Fleur Hudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fleur Hudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fleur Hudson more than expected).

Fields of papers citing papers by Fleur Hudson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fleur Hudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fleur Hudson. The network helps show where Fleur Hudson may publish in the future.

Co-authorship network of co-authors of Fleur Hudson

This figure shows the co-authorship network connecting the top 25 collaborators of Fleur Hudson. A scholar is included among the top collaborators of Fleur Hudson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fleur Hudson. Fleur Hudson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Hudson, Fleur, et al.. (2021). Acute Chagas Disease Manifesting as Orbital Cellulitis, Texas, USA. Emerging infectious diseases. 27(11). 2937–2939. 3 indexed citations

Cordero, Ana I. Hernández, Chen Xi Yang, Ma’en Obeidat, et al.. (2020). DNA methylation is associated with airflow obstruction in patients living with HIV. Thorax. 76(5). 448–455. 16 indexed citations

Yang, Chen Xi, Ma’en Obeidat, Michael S. Kobor, et al.. (2020). Occurrence of Accelerated Epigenetic Aging and Methylation Disruptions in Human Immunodeficiency Virus Infection Before Antiretroviral Therapy. The Journal of Infectious Diseases. 223(10). 1681–1689. 23 indexed citations

Engen, Nicole, Kathy Huppler Hullsiek, Waldo Belloso, et al.. (2019). A randomized evaluation of on-site monitoring nested in a multinational randomized trial. Clinical Trials. 17(1). 3–14. 11 indexed citations

Grady, Christine, Giota Touloumi, A. Sarah Walker, et al.. (2017). A randomized trial comparing concise and standard consent forms in the START trial. PLoS ONE. 12(4). e0172607–e0172607. 22 indexed citations

Grarup, Jesper, et al.. (2016). Lessons learned: Infrastructure development and financial management for large, publicly funded, international trials. Clinical Trials. 13(2). 127–136. 11 indexed citations

Grarup, Jesper, C CAREY, Fleur Hudson, et al.. (2015). Challenges, successes and patterns of enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Medicine. 16(S1). 14–23. 7 indexed citations

Raffi, François, Abdel G. Babiker, Laura Richert, et al.. (2014). Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.. The Lancet Neurology. 384(9958). 1 indexed citations

Raffi, François, Abdel G. Babiker, Laura Richert, et al.. (2014). Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial. The Lancet. 384(9958). 1942–1951. 120 indexed citations

10.

Hullsiek, Katherine Huppler, Jonathan Kagan, Nicole Engen, et al.. (2014). Investigating the Efficacy of Clinical Trial Monitoring Strategies: Design and Implementation of the Cluster Randomized START Monitoring Substudy. Therapeutic Innovation & Regulatory Science. 49(2). 225–233. 10 indexed citations

11.

Holodniy, Mark, Sheldon T. Brown, D. William Cameron, et al.. (2011). Results of Antiretroviral Treatment Interruption and Intensification in Advanced Multi-Drug Resistant HIV Infection from the OPTIMA Trial. PLoS ONE. 6(3). e14764–e14764. 15 indexed citations

12.

Mead, Simon, Gosala Gopalakrishnan, Andrew G.B. Thompson, et al.. (2011). PRION-1 scales analysis supports use of functional outcome measures in prion disease. Neurology. 77(18). 1674–1683. 23 indexed citations

13.

Mead, Simon, et al.. (2009). Clinical trials and methodological problems in prion diseases Reply. The Lancet Neurology. 1 indexed citations

14.

Read, Tim, Dianne Carey, Patrick Mallon, et al.. (2009). Efavirenz plasma concentrations did not predict cessation of therapy due to neuropsychiatric symptoms in a large randomized trial. AIDS. 23(16). 2222–2223. 13 indexed citations

15.

Collinge, John, Michele Gorham, Fleur Hudson, et al.. (2009). Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial. The Lancet Neurology. 8(4). 334–344. 184 indexed citations

16.

Mead, Simon, Peter Rudge, Fleur Hudson, et al.. (2009). Clinical trials and methodological problems in prion diseases – Authors' reply. The Lancet Neurology. 8(9). 782–783. 1 indexed citations

17.

Bucciardini, Raffaella, Vincenzo Fragola, M. Mirra, et al.. (2007). Health-Related Quality of Life Outcomes in HIV-Infected Patients Starting Different Combination Regimens in a Randomized Multinational Trial: The INITIO-QoL Substudy. AIDS Research and Human Retroviruses. 23(10). 1215–1222. 14 indexed citations

18.

Zama, Aparna Mahakali, Fleur Hudson, & Mary A. Bedell. (2005). Analysis of Hypomorphic KitlSl Mutants Suggests Different Requirements for KITL in Proliferation and Migration of Mouse Primordial Germ Cells1. Biology of Reproduction. 73(4). 639–647. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact